Sandoz Conducting Voluntary Recall



http://www.rxwiki.com/fda-alerts/injectable-product-voluntarily-recalled-due-discovery-matter-vials

Sandoz is conducting a voluntary nationwide recall to the hospital/user level of two lots of its methotrexate sodium, USP, 25 mg/mL, 40 mL vial injectable product in the US, due to the discovery of particulate matter in vials during routine quality examination of retention samples at the manufacturer.

To learn more visit, http://www.rxwiki.com/methotrexate

source

Leave a Reply

Your email address will not be published.

close

Health Alerts

Get new posts by email:
RSS52.1k
Follow by Email77.5k
Twitter